Altieri V - Search Results

1

cAMP induced modifications of HOX D gene expression in prostate cells allow the identification of a chromosomal area involved in vivo with neuroendocrine differentiation of human advanced prostate cancers.

Cantile M, Kisslinger A, Cindolo L, Schiavo G, D'Antò V, Franco R, Altieri V, Gallo A, Villacci A, Tramontano D, Cillo C. Cantile M, et al. Among authors: altieri v. J Cell Physiol. 2005 Nov;205(2):202-10. doi: 10.1002/jcp.20384. J Cell Physiol. 2005. PMID: 15895411

2

Hyperexpression of locus C genes in the HOX network is strongly associated in vivo with human bladder transitional cell carcinomas.

Cantile M, Cindolo L, Napodano G, Altieri V, Cillo C. Cantile M, et al. Among authors: altieri v. Oncogene. 2003 Sep 25;22(41):6462-8. doi: 10.1038/sj.onc.1206808. Oncogene. 2003. PMID: 14508527

3

Not traditional prognostic factors in human conventional renal carcinoma.

Cindolo L, Cantile M, Galasso R, Marsicano M, Napodano G, Altieri V. Cindolo L, et al. Among authors: altieri v. Minerva Urol Nefrol. 2001 Dec;53(4):211-9. Minerva Urol Nefrol. 2001. PMID: 11753249 Review.

4

Overexpression of chromatin assembly factor-1 (CAF-1) p60 is predictive of adverse behaviour of prostatic cancer.

Staibano S, Mascolo M, Mancini FP, Kisslinger A, Salvatore G, Di Benedetto M, Chieffi P, Altieri V, Prezioso D, Ilardi G, De Rosa G, Tramontano D. Staibano S, et al. Among authors: altieri v. Histopathology. 2009 Apr;54(5):580-9. doi: 10.1111/j.1365-2559.2009.03266.x. Epub 2009 Mar 20. Histopathology. 2009. PMID: 19309489

5

galectin-1 and galectin-3 expression in human bladder transitional-cell carcinomas.

Cindolo L, Benvenuto G, Salvatore P, Pero R, Salvatore G, Mirone V, Prezioso D, Altieri V, Bruni CB, Chiariotti L. Cindolo L, et al. Among authors: altieri v. Int J Cancer. 1999 Feb 19;84(1):39-43. doi: 10.1002/(sici)1097-0215(19990219)84:1<39::aid-ijc8>3.0.co;2-e. Int J Cancer. 1999. PMID: 9988230

6

[Erectile dysfunction in kidney transplanted patients].

Musone D, Cindolo L, Altieri V, Russo D. Musone D, et al. Among authors: altieri v. Minerva Urol Nefrol. 2003 Sep;55(3):193-7. Minerva Urol Nefrol. 2003. PMID: 14610438 Italian.

7

Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study.

Cindolo L, Benincasa G, Autorino R, Domizio S, De Rosa G, Testa G, D'Armiento M, Altieri V. Cindolo L, et al. Among authors: altieri v. Oncol Rep. 2001 Mar-Apr;8(2):269-71. Oncol Rep. 2001. PMID: 11182038

8

A preoperative clinical prognostic model for non-metastatic renal cell carcinoma.

Cindolo L, de la Taille A, Messina G, Romis L, Abbou CC, Altieri V, Rodriguez A, Patard JJ. Cindolo L, et al. Among authors: altieri v. BJU Int. 2003 Dec;92(9):901-5. doi: 10.1111/j.1464-410x.2003.04505.x. BJU Int. 2003. PMID: 14632843

9

Standard versus hydrophilic catheterization in the adjuvant treatment of patients with superficial bladder cancer.

Cindolo L, Palmieri EA, Autorino R, Salzano L, Altieri V. Cindolo L, et al. Among authors: altieri v. Urol Int. 2004;73(1):19-22. doi: 10.1159/000078798. Urol Int. 2004. PMID: 15263787 Clinical Trial.

10

Urotensin II receptor on preoperative biopsy is associated with upstaging and upgrading in prostate cancer.

De Cobelli O, Buonerba C, Terracciano D, Bottero D, Lucarelli G, Bove P, Altieri V, Coman I, Perdonà S, Facchini G, Berretta M, Di Lorenzo G, Grieco P, Novellino E, Franco R, Caraglia M, Manini C, Mirone V, De Placido S, Sonpavde G, Ferro M. De Cobelli O, et al. Among authors: altieri v. Future Oncol. 2015 Nov;11(22):3091-8. doi: 10.2217/fon.15.249. Epub 2015 Sep 18. Future Oncol. 2015. PMID: 26381851 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

136 results

Search Page

Filters